NEW YORK (
CHANGE IN RATINGS
(A - Get Report)
was downgraded at Stifel Nicolaus to hold from buy. Valuation call, said Stifel Nicolaus.
was upgraded at FBR Capital Markets to outperform from market perform. $71 price target. Company is seeing higher sales and managing its solvency margin ratio better, FBR Capital Markets said.
(BBT - Get Report)
was upgraded at Oppenheimer to outperform from perform. Valuation call, based on a $40 price target, Oppenheimer said.
was downgraded at Robert Baird to neutral from outperform. $39 price target. Estimates also cut, given lower near-term demand, Robert Baird said.
was downgraded at Bank of America/Merrill Lynch to neutral. Valuation call, based on a $41 price target, BofA/Merrill said.
was upgraded at Canaccord Genuity to buy from hold. $80 price target. Company is leveraged to continued demand for lighting and is seeing lower costs, Canaccord Genuity said.
was upgraded at Goldman Sachs to buy. $89 price target. Company deserves a premium valuation, Goldman said.
was upgraded at Canaccord Genuity to buy from hold. $80 price target. Positive checks show improving fundamentals across the industry, Canaccord Genuity said.
(DUK - Get Report)
was upgraded at Deutsche Bank to buy from hold. $74 price target. Sector appears attractively valued, Deutsche Bank said.
was upgraded at Jefferies to hold from underperform. $36.50 price target. Valuation call, Jefferies said.
was downgraded at Goldman Sachs to sell from neutral. Valuation call, based on a $22 price target, Goldman Sachs said.
was downgraded at Societe Generale to hold from buy. $86 price target. Restructuring process could take longer than expected, Societe Generale said.
was upgraded at Morgan Stanley to overweight. $33 price target. GoHealth relationship can drive near-term growth, Morgan Stanley said.
(JCP - Get Report)
was downgraded at Argus to hold from buy. Share offering could dilute investors by more than 40%, Argus said.
was upgraded at Robert Baird to outperform from neutral. $38 price target. Europe can drive near-term growth, Robert Baird said.